ROCHE HLDGS AG SPN ADR EACH REP 0.125GENUS (RHHBY)

31.89
0.26 0.81
OTC
Prev Close 32.15
Open 32.19
Day Low/High 31.84 / 32.19
52 Wk Low/High 25.25 / 36.82
Volume 271.68K
Exchange OTC
Shares Outstanding 5620.50B
Market Cap 181.37B
Div & Yield N.A. (N.A)

Latest News

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Roche Holding AG To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Roche Holding AG To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

Positive Phase III Results For Genentech's Emicizumab In Hemophilia A Published In The New England Journal Of Medicine

Positive Phase III Results For Genentech's Emicizumab In Hemophilia A Published In The New England Journal Of Medicine

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that data from HAVEN 1, a Phase III study evaluating once-weekly subcutaneous emicizumab prophylaxis (preventative) in adults and...

ROCHE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Roche Holding AG To Contact The Firm

ROCHE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Roche Holding AG To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Roche Holding AG ("Roche" or the "Company") (Other OTC:RHHBY) of the August 7, 2017 deadline to seek the role of lead plaintiff in a...

Roche Expands Into App-Based Digital Health With mySugr Deal

Roche Expands Into App-Based Digital Health With mySugr Deal

Financial terms of the acquisition were not disclosed.

Roche Expands Harmony® Prenatal Test To Include 22q11.2 Deletion Testing

-- New test option will be available globally mid-2017 in the Harmony CE-IVD kit and through the test send-out service from Ariosa Diagnostics Inc.

Genentech's Emicizumab Showed Positive Results In Phase III Studies (HAVEN 1 And HAVEN 2) In Hemophilia A With Inhibitors

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive data from the primary analysis of the Phase III HAVEN 1 study in adults and adolescents and interim analysis of the Phase III...

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Roche Holding AG Shareholders And A Lead Plaintiff Deadline Of August 7, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Roche Holding AG (OTCMKTS: RHHBY) who purchased shares between March 2, 2017 and June 5, 2017.

Roche Receives FDA Approval For Fourth-generation HIV Combination Antigen-antibody Assay --allowing Detection Of Infection With High Sensitivity And Specificity

Elecsys® HIV combi PT assay demonstrates commitment to improving efficiency by aiding labs in consolidating testing with other routine immunoassays

New Data At EAN Show Genentech's Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures Of Disease Progression In Relapsing And Primary Progressive Multiple Sclerosis

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new post-hoc analyses from the OCREVUS TM (ocrelizumab) Phase III clinical trial program in people with relapsing and primary...

FDA Approves RITUXAN HYCELA (Rituximab And Hyaluronidase Human) For Subcutaneous Injection In Certain Blood Cancers

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.

The Klein Law Firm Announces A Class Action Filed On Behalf Of Roche Holding AG Shareholders And A Lead Plaintiff Deadline Of August 7, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Roche Holding AG (OTCMKTS:RHHBY) who purchased shares between March 2, 2017 and June 5, 2017.

RHHBY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Roche Holding AG And A Lead Plaintiff Deadline Of August 7, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Roche Holding AG ("Roche...

RHHBY SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Roche Holding AG And A Lead Plaintiff Deadline Of August 7, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Roche Holding AG ("Roche...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Roche Holding AG To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Roche Holding AG Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 7, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Roche Holding AG ("Roche Holding") (OTCMKTS:RHHBY) between March...

Novartis Secures European Approval For Biosimilar Cancer Treatment Rixathon

Novartis Secures European Approval For Biosimilar Cancer Treatment Rixathon

Novartis said Monday that it has received EC approval for a blood cancer treatment known as Rixathon, a biosimilar version of Roche's Rituxan that generated $7.5 billion in 2016 sales.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Roche Holding AG Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 7, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Roche Holding AG ("Roche Holding") (OTCMKTS: RHHBY) between...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Roche Holding AG

The Klein Law Firm announces the commencement of an investigation of Roche Holding AG (OTCMKTS: RHHBY) concerning possible violations of federal securities laws.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Roche Holding AG

The Klein Law Firm announces the commencement of an investigation of Roche Holding AG (OTCMKTS: RHHBY) concerning possible violations of federal securities laws.

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Roche Holding AG Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Roche Holding AG ("Roche" or the "Company") (OTC: RHHBY) securities between March 2, 2017...

RHHBY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Concerning Possible Securities Violations By Roche Holding AG

The Law Offices of Vincent Wong announce the commencement of an investigation concerning whether Roche Holding AG ("Roche Holding") (OTCMKTS:RHHBY) violated federal securities laws.

RHHBY SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Concerning Possible Securities Violations By Roche Holding AG

The Law Offices of Vincent Wong announce the commencement of an investigation concerning whether Roche Holding AG ("Roche Holding") (OTCMKTS: RHHBY) violated federal securities laws.

ROCHE LOSS NOTICE: Rosen Law Firm Reminds Roche Holding AG Investors Of Important Deadline In First Filed Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Roche Holding AG (OTCQX:RHHBY) from March 2, 2017 through June 5, 2017, inclusive (the "Class Period") of the important August 7,...